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ABSTRACT
Male breast cancer is a rare entity and accounts for 1% of all breast cancer cases with an average age of onset 67 years. Several risk 
factors have been identified, such as genetic and hormonal abnormalities. Even though more data is emerging about this disease, the 
poor level of awareness often results in late presentation and delayed diagnosis in our country.The present study reported the case of 
a 63 year old man who was diagnosed with an advanced invasive ductal carcinoma without any important risk factors. The case is 
presented for the rarity and to discuss awareness, regarding early diagnosis and proper management.
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Male breast cancer (MBC) is a rare disease with an estimated prevalence of 0.5-1% amongst all breast carcinoma [1]. The disease is more common in the 
elderly population and mostly present as an aggressive course on 
presentation. Although etiology is not known, the current literature 
suggests that genetic factors including BRCA2 mutations, family 
history, age, androgen/estrogen imbalance, and environmental 
exposures may predispose to male breast cancer [2]. Invasive 
ductal carcinoma is the most common subtypes (>90%) amongst 
invasive carcinoma of the male breast, whereas, ductal carcinoma 
in-situ (DCIS) and lobular carcinomas are rare [3]. Male breast 
cancers are more often hormone receptor positive (estrogen 
receptor and progesterone receptor) and less often overexpress 
her2-neu. The most common presentation is a painless, firm, sub-
areolar mass. 
Here, we are reporting the case of a 63-year-old male with the 
left breast cancer, infiltrating ductal adenocarcinoma type, clinical 
stage IIIA, positive hormone receptors, treated with left modified 
radical mastectomy with level-2 axillary clearance with subsequent 
adjuvant chemotherapy/radiotherapy. The patient improved 
satisfactorily, following up to 12 months since the beginning.
CASE REPORT
A 63-years-old male presented to the department with a complaint 
of progressive swelling of the left breastforone year. The swelling 
was painless, located at the upper quadrants of the left breast 
and progressively increased for the last 4 months (Figure 1). 
He had no significant past medical or family history. He was 
not taking any medication. He did not drink alcohol and had an 
occasional smoking history. There was no history suggestive 
of hyperoestrogenic states found in liver disease, Klinefelter’s 
syndrome, obesity and gonadal dysfunction resulting from a 
congenital inguinal hernia, testicular injury, orchidectomy, 
gynaecomastia and mumps orchitis.
On physical examination, around 4 х 2 cm size mass was 
found in the left upper quadrant of the breast which is firm to 
hard in consistency and involving the skin. Left axillary lymph 
Figure 1: A lump in the left breast
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nodes were palpable.There was no nipple discharge or ulceration. 
The other breast was normal on examination. 
Blood examination including complete hemogram, blood 
sugar, renal and liver function tests was normal. His serology tests 
for hepatitis B/C were negative and human immunodeficiency 
virus (HIV) status was also negative. High resolution sonography 
of the left breast has shown 42 х 28 mm size mass lesion in the left 
breast with the presence of minimal vascularity and also 52 х 26 
mm size nodal mass in the left axilla.Fineneedleaspiration cytology 
(FNAC) of the breast wassuggestive of ductal carcinoma (Figure 
2). Preoperative chest x-ray was normal and ultrasound of the 
hepatobiliary system showedno liver metastasis. Full metastatic 
work-up could not be done because of financial constrain. 
The patient was taken for surgery and the left modified radical 
mastectomy (MRM) withlevel-2 axillary clearance (Figure 3 
and 4) was done.The skin was primarily closed after MRM. The 
histopathological report showed infiltrating ductalcarcinoma 
of the breast with extensive fibrosis and calcification with free 
surgical margin, ER/PR positive, grading of IIIA andmetastatic 
axillary lymph nodes (Figure 5). Postoperatively, he was doing 
well and was put for adjuvant chemotherapy and radiotherapy by 
the oncology department.
DISCUSSION
Male breast cancer is a rare tumor and accounts for less than 
1% of breast cancers, but the incidence seems to beincreasing 
[4]. The median age of onset is around 67years, which is almost 
one decade later than in female breast cancer. As diagnosis is 
not often considered and screening mammography is rarely 
done, men often present with advanced disease. A very few 
research is going on MBC and risk is mostly found to be 
hormonally driven,resulting from estrogen excess or androgen 
deficiency [5]. 
Various conditions have been reported to be associated with 
an increased risk for MBC: Klinefelter’ssyndrome (XXY), 
cryptorchidism, chronic liver disorders, such as cirrhosis, 
chronic alcoholism, mumps orchitis, undescended testes, or 
testicular injury, orchiectomy, late puberty, and infertility. 
Gynecomastiaalone is not a risk factor for MBC. Family history 
Figure 2: Fine needle aspiration cytology (FNAC) smear showing 
malignant ductal epithelial cells mostly in clusters. (MGG stain, 10X)
Figure 3: Modified radical mastectomy
Figure 4: Level 2 dissection
Figure 5: Low power view shows infiltrating areas of malignant 
ductal epithelial cells in sheets. (H & E, 10X).
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of MBC is another important risk factor and may present in one 
fourth of the patient [6].Also, men who carries BRCA2 mutation 
and rarely BRACA1 mutation has an additional risk factor to 
develop MBC. In our case, no such risk factor could be identified. 
As reported by Jagtap SV et al, although most of the male breast 
cancer is unilateral, there are few case reports of rare synchronous 
bilateral breast cancer in elderly male [7]. The predominant 
clinical presentation is painless mass followed changes on nipple-
areola complex in the form of nipple fixation, bloody discharge, 
oedema, retraction, eczema or ulceration [8].
Although biologically MBC behaves similar to female breast 
cancer, there are some basic pathologicaldifferences. They 
are predominantly ductal in origin as themale breast normally 
contains only ducts and no lobules.The most common type of 
MBC is infiltrating ductal carcinoma (84% to 94%) followed by 
a very rare occurrence of ductal carcinomas insitu and lobular 
carcinoma [4-5].Most of the MBC express ER/PR positive (that 
90% and 81-96% respectively) and is greater than female breast 
cancer [4].
The male breast can be affected by a variety of benign and 
malignant disorders like gynaecomastia, abscess, Mondor 
disease and neoplastic (benign and malignant) lesions.Clinical 
examination remains the most important tool in the evaluation 
of apalpable mass in men.Radiographic assessment by both 
mammography and ultrasonography has an important role to 
play especially to exclude malignancy. Ultrasound of the breast 
showed a hypoechoic masswith irregular margins in patients with 
MBC. Primary mammographiccharacteristics in MBC include a 
solid mass which is eccentricto the nipple with speculatedmargins. 
Micro calcifications are rare in MBC and if occurs they tend to 
be large, round and coarser in appearance. Fine-needleaspiration 
cytology and/or guided core biopsy are necessary to make the 
final diagnosis [8].
Surgery is the mainstay of treatment for MBC and the surgical 
gold standard procedure is modifiedradical mastectomy followed 
by a radical mastectomy, total mastectomy, and lumpectomy 
with or without irradiation [6].Adjuvant chemotherapy with 
cytotoxic agents has beenshown benefit in men with lymphnode-
positive cancer in a few studies [6]. Adjuvant radiotherapy (RT)
following surgery may help in selected locally invasive breast 
cancer, however RT should include the internalmammary nodes 
in addition to the routine fields used inwomen. The indications 
for post-mastectomy radiation includes: men with large tumours, 
locally advanced disease, extensive axillary nodal involvement 
or poor prognostic factors such as high histological grade and 
vascular invasion. Since the majority of male breast cancer is 
hormone receptor-positive, thereforehormonal therapy plays 
an integral part in the treatment. Tamoxifen is the mainstay 
ofhormonal therapy for breast cancer and studies of Tamoxifen 
in men, given for two years, have shown improvement in both 
disease free, and so the effect of this treatment [4,8].
Aromatase inhibitors (AI: anastrozole, letrozole, and 
exemestane) may have a potentially promising role in the optimal 
management for metastatic MBC patients. Especially, when co-
administered with gonadotropin - releasing hormone (GnRH) 
analogues it seems to increase the rate of clinical benefit [9-10]. 
Although the outlook of MBC is equivalent to that in stage-
matched female patients, an overall prognosis is poor because of 
late presentation and associated co-morbidities.
CONCLUSION
Male breast cancer is rare entitywith most of the data in the 
form of sporadic case reports.The disease should be suspected 
in an elderly male with palpable breast swelling. Early clinical 
diagnosis is crucial in improving the prognosis of patients with 
MBC. Appropriate treatment, if instituted promptly and early in 
the course of the disease, has the potential to induce remission. 
REFERENCES
1. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a 
review of 229 patients who presented to the Princess Margaret Hospital 
during 40 years: 1955–1996. Cancer 1999;85:629-39.
2. Ferzoco RM, Ruddy KJ. The Epidemiology of Male Breast Cancer. 
CurrOncol Rep 2016;18:1.
3. Giordano SH, Cohen DS, Buzdar AU et al. Breast carcinoma in men: 
a population-based study. Cancer 2004;101:51-7.
4. Lanitis S, Rice AJ, Vaughan A, Cathcart P, Filippakis G, Al Mufti R 
et al. Diagnosis and management of male breast cancer. World J Surg 
2008;32:2471-6.
5. Goodman MT, Tung KH, Wilkens LR. Comparative epidemiology of breast 
cancer among men and women in the US, 1996 to 2000. Cancer Causes 
Control 2006;17:127-36.
6. De los Santos JF, Buchholz TA. Carcinoma of the male breast. Curr Treat 
Options Oncol 2000;1:221-7.
7. Jagtap SV, Chougule PG, Khatib W, Shukla DB, Jagtap SS. Male breast 
cancer: presenting as synchronous, large, bilateral masses. J ClinDiagn Res 
2014;8(4):FD07-8.
8. Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: 
a review of clinical management. Breast Cancer Res Treat 2007;103:11-21.
9. Volm MD. Male breast cancer. Curr Treat Options Oncol 2003;4:159-64.
10. Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, 
Psaltopoulou T. Aromatase inhibitors in male breast cancer: a pooled 
analysis.Breast Cancer Res Treat 2015;151:141-7.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Hazarika D, Barua PP, Barman B. Carcinoma of male 
breast: A rare case report from north east india with review of literature. Indian 
J Case Reports. 2019;5(3):219-221.
Doi: 10.32677/IJCR.2019.v05.i03.007
